Background: Unilateral focused ultrasound ventral intermediate thalamotomy (Vim-FUS) is effective in treating Parkinson's disease (PD) tremor. Ultrasound ablation of the subthalamic nucleus (STN-FUS) has demonstrated efficacy in improving all cardinal motor features of PD, including tremor.
Objective: To compare the efficacy in parkinsonian tremor control between Vim-FUS and STN-FUS.
Methods: Retrospective, two-center study including consecutive PD patients with medication-refractory tremor who underwent unilateral Vim-FUS or STN-FUS between June 2015 and August 2022. Patients scored ≥2 for postural and/or resting tremor on the most affected body side in the off-medication state. The primary outcome was the between-group difference in tremor improvement on the treated side at 12-month follow-up, including a responder's analysis. Data regarding safety, global motor status, and dopaminergic requirements were also collected. Group comparisons used repeated measures ANOVA with Bonferroni correction; statistical significance for P < 0.05.
Results: Among 175 patients treated at the two sites, 63 were included (23 Vim-FUS, 40 STN-FUS). At baseline, both groups were equivalent in disease duration (6.7 ± 3.8 vs. 6.1 ± 3.4 years, P = 0.48) and tremor severity (5.7 ± 1.5 vs. 5.9 ± 2.5, P = 0.7). While the benefit in tremor was equivalent between the groups at 4 months (P = 0.15), tremor reduction was greater in STN- FUS patients at 12 months (4.4 ± 2.0, 95% CI 3.7-5.0 compared with 2.7 ± 3.7, 95% CI 1.1-4.3 for Vim-FUS, P = 0.012). In 47.5% (19/40) of STN-FUS patients tremor was completely abolished versus 8.7% (2/23) in Vim-FUS patients (P < 0.01). Most adverse events were mild (91%) and resolved by 12 months.
Conclusions: STN-FUS and Vim-FUS significantly improved medication-refractory PD tremor; however, subthalamotomy might have greater and more sustained effect. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/mds.30159 | DOI Listing |
Objective: Quantitative time of flight in transmission mode ultrasound computed tomography (TFTM USCT) is a promising, cost-effective, and non-invasive modality, particularly suited for functional imaging. However, TFTM USCT encounters resolution challenges due to path information concentration in specific medium regions and uncertainty in transducer positioning. This study proposes a method to enhance resolution and robustness, focusing on low-frequency TFTM USCT for pulmonary imaging.
View Article and Find Full Text PDFWorld J Urol
March 2025
Desai Sethi Urology Institute, University of Miami, Miller School of Medicine, Miami, FL, USA.
Purpose: Despite the growing adoption of HIFU treatment for localized prostate cancer (PC), standardized criteria for evaluating success and predicting recurrence remain undefined. Herein, we analyze the predictive value of noninvasive tools such as PSA dynamics and MRI to determine recurrence.
Methods: We identified from our HIFU therapy prospective registry patients who developed biopsy-proven recurrence, between 2016 and 2023.
AJR Am J Roentgenol
March 2025
Department of Radiology, Duke University School of Medicine.
Architectural distortions (ADs) detected on digital breast tomosynthesis (DBT) are more frequently associated with nonmalignant pathologies than those detected on digital mammography. To evaluate outcomes of ADs detected by DBT alone with no ultrasound correlate and nonmalignant results on core needle biopsy (CNB) when adopting a management strategy selectively incorporating imaging surveillance. This retrospective study included patients with ADs detected by DBT alone with no ultrasound correlate and nonmalignant results on stereotactic CNB with 12 vacuum-assisted 9-gauge cores from July 1, 2020, to December 31, 2023.
View Article and Find Full Text PDFBioelectromagnetics
April 2025
Care & Cure Lab of the Electromagnetics Group (EM4Care+Cure), Department of Electrical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.
Neuromodulation with low-intensity focused ultrasound (LIFUS) holds significant promise for noninvasive treatment of neurological disorders, but its success relies heavily on accurately targeting specific brain regions. Computational model predictions can be used to optimize LIFUS, but uncertain acoustic tissue properties can affect prediction accuracy. The Monte Carlo method is often used to quantify the impact of uncertainties, but many iterations are generally needed for accurate estimates.
View Article and Find Full Text PDFRheumatology (Oxford)
March 2025
Section of Cardiorespiratory Medicine, Victor Phillip Dahdaleh Heart and Lung Research Institute, University of Cambridge, Cambridge, UK.
Imaging plays an important role in the clinical management of patients with large-vessel vasculitis (LVV), both to confirm the diagnosis at the time of initial presentation and to identify disease relapses in individuals with established disease. The big advantage of PET imaging over other non-invasive imaging modalities is the ability to employ targeted radionuclide probes to localize and track cellular pathways, providing in vivo assessments of disease activity. While 18F-fluorodeoxyglucose (FDG) has good diagnostic accuracy for LVV, this tracer is taken up by all glucose metabolizing cells in the vessel wall and so non-specific arterial uptake that is often unrelated to inflammatory disease activity can occur in patients despite a good clinical response to treatment.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!